Literature DB >> 8858453

Critical appraisal of E test for the detection of fluoroquinolone resistance.

R N Jones1, M E Erwin, J L Croco.   

Abstract

The ability of E test to accurately detect fluoroquinolone resistance was compared with an agar dilution reference method. Nearly 300 isolates belonging to 26 different species (62.5% with documented ciprofloxacin resistance) were tested with ciprofloxacin, fleroxacin, levofloxacin, norfloxacin, ofloxacin, and sparfloxacin. In contrast to earlier reports, E test MIC values for pneumococci and all rapid growing aerobes were routinely higher (approximately 0.5 log2 dilution step) than agar dilution results. The E test stable-gradient method also efficiently identified fluoroquinolone-resistant subpopulations which were not detected by the reference procedure with the standard inoculum. Categorical agreement for 1710 test comparisons was approximately 90% with no very major, false-susceptible errors. We found the E test to be a valid, reproducible method for fluoroquinolone susceptibility testing that provided quantitative results and produced a conservative (1.6% false-resistant results) assessment of susceptibility of bacteria including isolates of Streptococcus pneumoniae and Pseudomonas aeruginosa to compounds in this antimicrobial class.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858453     DOI: 10.1093/jac/38.1.21

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.

Authors:  T A Davies; L M Kelly; M R Jacobs; P C Appelbaum
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Antimicrobial susceptibility testing of Gram-positive and -negative bacterial isolates directly from spiked blood culture media with Raman spectroscopy.

Authors:  H E Dekter; C C Orelio; M C Morsink; S Tektas; B Vis; R Te Witt; W B van Leeuwen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-08       Impact factor: 3.267

3.  Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.

Authors:  C L Clark; M R Jacobs; P C Appelbaum
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones.

Authors:  Fatemeh Rafii; Miseon Park; John S Novak
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Levofloxacin pharmacokinetics in adult cystic fibrosis.

Authors:  Carlton K K Lee; Michael P Boyle; Marie Diener-West; Lois Brass-Ernst; Michelle Noschese; Pamela L Zeitlin
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

6.  Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories.

Authors:  Giovanni Pietro Gesu; Federico Marchetti; Laura Piccoli; Annalisa Cavallero
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.